- Home
- LQDA vs CCEC Comparison
LQDA vs CCEC Comparison
Compare LQDA & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDA
- CCEC
- Stock Information
- Founded
- LQDA 2004
- CCEC 2007
- Country
- LQDA United States
- CCEC Greece
- Employees
- LQDA N/A
- CCEC N/A
- Industry
- LQDA Biotechnology: Pharmaceutical Preparations
- CCEC Marine Transportation
- Sector
- LQDA Health Care
- CCEC Consumer Discretionary
- Exchange
- LQDA Nasdaq
- CCEC Nasdaq
- Market Cap
- LQDA 1.2B
- CCEC 1.4B
- IPO Year
- LQDA 2018
- CCEC 2007
- Fundamental
- Price
- LQDA $12.21
- CCEC $23.65
- Analyst Decision
- LQDA Strong Buy
- CCEC Buy
- Analyst Count
- LQDA 9
- CCEC 2
- Target Price
- LQDA $27.67
- CCEC $24.00
- AVG Volume (30 Days)
- LQDA 2.7M
- CCEC 8.1K
- Earning Date
- LQDA 08-06-2025
- CCEC 08-01-2025
- Dividend Yield
- LQDA N/A
- CCEC 2.54%
- EPS Growth
- LQDA N/A
- CCEC 44.72
- EPS
- LQDA N/A
- CCEC 3.36
- Revenue
- LQDA $14,144,000.00
- CCEC $402,628,000.00
- Revenue This Year
- LQDA $185.38
- CCEC $19.03
- Revenue Next Year
- LQDA $350.95
- CCEC $13.94
- P/E Ratio
- LQDA N/A
- CCEC $40.82
- Revenue Growth
- LQDA N/A
- CCEC 69.94
- 52 Week Low
- LQDA $8.26
- CCEC $14.09
- 52 Week High
- LQDA $19.41
- CCEC $24.33
- Technical
- Relative Strength Index (RSI)
- LQDA 35.27
- CCEC N/A
- Support Level
- LQDA $11.85
- CCEC N/A
- Resistance Level
- LQDA $13.83
- CCEC N/A
- Average True Range (ATR)
- LQDA 0.68
- CCEC 0.00
- MACD
- LQDA -0.19
- CCEC 0.00
- Stochastic Oscillator
- LQDA 12.23
- CCEC 0.00
About LQDA Liquidia Corporation
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
About CCEC Capital Clean Energy Carriers Corp. Common Share
Capital Clean Energy Carriers Corp is an international shipping company. It is the platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.